Amber Patterson, MD is a world-renowned allergy/immunology expert and the US ambassador for intralymphatic allergen immunotherapy (ILIT™). Before founding Auni Allergy®, she developed the first US clinical trial for ILIT™ (first in the world for pediatrics) as faculty at the Ohio State University Wexner Medical Center and Nationwide Children’s hospital where she founded the Center for Immunotherapy. She holds several patents on novel allergy drug and testing devices.

Dr. Patterson leads as chair of the American Academy of Allergy Asthma and Immunology (AAAAI) immunotherapy and diagnostics committee. She is a board-certified allergist/immunologist, fellow of both the AAAAI and the American College of Allergy Asthma and Immunology, as well as clinical assistant professor in the University of Toledo College of Medicine. Believing in the powerful connection between mind and body, she also volunteers on her local hospital foundation (Blanchard Valley) and community recreation center (YMCA) boards of directors, aiming to co-create positive community resources for physical, mental, and spiritual growth. As a wife and mother of four, Amber’s hobbies include investing in her children, relaxing at the lake with her husband, and traveling the world.

Her company Auni Allergy® is a family-owned allergy medical service chain with 9 practices in 4 states and a research and development division headquartered in Findlay, OH. The company was founded in 2020 with a dream of providing people with allergies and immune dysfunction access to convenient treatment options that are safe and effective. Dr. Amber Patterson’s early work with ILIT™ was the scientific foundation for the company. ILIT™ is an ultrasound-guided injection for rapid aeroallergen immunotherapy, reducing allergy treatment time from 100s of shots over 5 years to 3 injections over 8 weeks. Rooted in science, driven by patient needs, Auni Allergy® is pioneering the concept of prioritizing allergy/immunology treatments to fit patients’ lifestyles.

Licensing innovative treatment methods to independent physicians and institutions is key to bringing access to ILIT™ nationwide. Together we are shifting the paradigm of how allergists treat allergies. In 2022 the licensing and clinical service divisions began doing business as Auni Allergy®, and the first license was granted to Shepherd Allergy in West Virginia. 2023 brought the organization of our licensed medical practices into a healthcare learning network, the Auni® ILIT™ Learning Network and opening of full-service Auni Allergy®-branded allergy/immunology clinics in Northwest Ohio (Findlay, Bowling Green and plans for 2024 Perrysburg). In 2024 our Auni® Research and development division was selected as a clinical site for phase 2 and 3 pharmaceutical research trials, and we continue development of patented food allergy and venom treatments which will revolutionize the future for families living with food & venom allergies.

Dr. Patterson is a proud member of CIIC, a place where physician entrepreneurs collaborate and thrive for the benefit of their patients.